1.
Hsiao AJ, Chen LH, Lu TH. Ten leading causes of death in Taiwan: a comparison of two
grouping lists. J Formos Med Assoc. 2015;114(8):679-80.
2.
Health Promotion Administration, Ministry of Health and Welfare. 2016 Annual report
of health promotion administration. Taipei City: Health Promotion Administration,
Ministry of Health and Welfare; 2016.
3.
Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially
modifiable risk factors associated with myocardial infarction in 52 countries (the
INTERHEART study): case-control study. Lancet. 2004;364(9438):937-52.
4.
Farhud DD. Impact of Lifestyle on Health. Iran J Public Health. 2015;44(11):1442-4.
5.
Torpy JM, Burke AE, Glass RM. Coronary heart disease risk factors. JAMA. 2009;302(21):2388. doi: 10.1001/jama.302.21.2388.
6.
Grundy SM, Bazzarre T, Cleeman J, D'Agostino RB Sr, Hill M, Houston-Miller N, et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk
patient for primary prevention: medical office assessment: Writing Group I. Circulation.
2000;101(1):E3-E11.
7.
Li YH, Ueng KC, Jeng JS, Charng MJ, Lin TH, Chien KL, et al. 2017 Taiwan lipid guidelines for high risk patients. J Formos Med Assoc. 2017;116(4):217-48.
8.
Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, et al. C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?
Circulation. 1999;100(1):96-102.
9.
Dudina, A., Cooney MT, Bacquer DD, Backer GD, Ducimetière P, Jousilahti P, et al.,
Relationships between body mass index, cardiovascular mortality, and risk factors:
a report from the SCORE investigators. Eur J Cardiovasc Prev Rehabil. 2011;18(5):731-42.
10.
Haskell WL. Exercise-induced changes in plasma lipids and lipoproteins. Prev Med.
1984;13(1):23-36.
11.
Huang J, FrohlichJ, Ignaszewski AP. The impact of dietary changes and dietary supplements
on lipid profile. Can J Cardiol. 2011;27(4):488-505.
12.
Mann S, Beedie C, Jimenez A. Differential effects of aerobic exercise, resistance
training and combined exercise modalities on cholesterol and the lipid profile: review,
synthesis and recommendations. Sports Med. 2014;44(2):211-21.
13.
Skoumas J, Pitsavos C, Panagiotakos DB, Chrysohoou C, Zeimbekis A, Papaioannou I,
et al. Physical activity, high density lipoprotein cholesterol and other lipids levels,
in men and women from the ATTICA study. Lipids Health Dis. 2003;2:3.
14.
Colberg SR, Hernandez MJ, Shahzad F. Blood glucose responses to type, intensity, duration,
and timing of exercise. Diabetes Care. 2013;36(10):e177. doi: 10.2337/dc13-0965.
15.
He BM, Zhao SP, Peng ZY. Effects of cigarette smoking on HDL quantity and function:
Implications for atherosclerosis. J Cell Biochem. 2013;114(11): 2431-6.
16.
Komiyama M, Wada H, Ura S, Yamakage H, Satoh-Asahara N, Shimatsu A, et al. Analysis of factors that determine weight gain during smoking cessation therapy.
PLoS One. 2013;8(8):e72010. doi: 10.1371/journal.pone.0072010.
17.
Gossett LK, Johnson HM, Piper ME, Fiore MC, Baker TB, Stein JH. Smoking intensity
and lipoprotein abnormalities in active smokers. J Clin Lipidol. 2009;3(6):372-8.
18.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density
lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
Clin Chem. 1972;18(6):499-502.
19.
McPherson RA, Pincus MR. Henry's clinical diagnosis and management by laboratory methods.
Philadelphia: Elsevier Health Sciences; 2011.
20.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical
and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention
and the American Heart Association. Circulation. 2003;107(3):499-511.
22.Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et
al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines.
Circulation. 2018;138(17):e426-83.
23.
Department of Health. Identification, evaluation, and treatment of overweight and
obesity in adults in Taiwan. Washington, DC: Department of Health; 2003.
24.
Richardson DB, Kaufman JS. Estimation of the relative excess risk due to interaction
and associated confidence bounds. Am J Epidemiol.2009;169(6):756-60.
25.
Kalilani L, Atashili J. Measuring additive interaction using odds ratios. Epidemiol
Perspect Innov.2006;3:5.
26.VanderWeele TJ. Reconsidering the denominator of the attributable proportion for interaction.
Eur J Epidemiol. 2013;28(10):779-84.
27.
VanderWeele TJ. Causal interactions in the proportional hazards model. Epidemiology.
2011;22(5):713-7.
28.
Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology.
1992;3(5):452-6.
29.
Zou GY. On the estimation of additive interaction by use of the four-by-two table
and beyond. Am J Epidemiol. 2008;168(2):212-24.
30.
StataCorp. Stata statistical software: release 13. College Station: StataCorp LP;
2013.
31.
Khurana M, Sharma D, Khandelwal PD. Lipid profile in smokers and tobacco chewers-a
comparative study. J Assoc Physicians India. 2000;48(9):895-7.
32.
Ohsawa M, Okayama A, Nakamura M, Onoda T, Kato K, Itai K, et al. CRP levels are elevated in smokers but unrelated to the number of cigarettes
and are decreased by long-term smoking cessation in male smokers. Prev Med. 2005;41(2):651-6.
33.
Frati AC, Iniestra F, Ariza CR. Acute effect of cigarette smoking on glucose tolerance
and other cardiovascular risk factors. Diabetes Care. 1996;19(2):112-8.
34.
Chelland Campbell S, Moffatt RJ, Stamford BA. Smoking and smoking cessation-the relationship
between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis.
2008;201(2):225-35.
35.
Bessembinders K, Wielders J, van de Wiel A. Severe hypertriglyceridemia influenced
by alcohol (SHIBA). Alcohol Alcohol. 2011;46(2):113-6.
36.
Volcik KA, Ballantyne CM, Fuchs FD, Sharrett AR, Boerwinkle E. Relationship of alcohol
consumption and type of alcoholic beverage consumed with plasma lipid levels: differences
between Whites and African Americans of the ARIC study. Ann Epidemiol. 2008;18(2):101-7.
37.
Imhof A, Woodward M, Doering A, Helbecque N, Loewel H, Amouyel P, et al. Overall alcohol
intake, beer, wine, and systemic markers of inflammation in western Europe: results
from three MONICA samples (Augsburg, Glasgow, Lille). Eur Heart J. 2004;25(23):2092-100.
38.
Egbung GE, Atangwho IJ, Odey OD, Ndiodimma VN. The lipid lowering and cardioprotective
effects of Vernonia calvoana ethanol extract in acetaminophen-treated rats. Medicines (Basel). 2017;4(4):90. doi: 10.3390/medicines4040090.
39.
Ford ES. Does exercise reduce inflammation? Physical activity and C-reactive protein
among U.S. adults. Epidemiology. 2002;13(5):561-8.
40.
Kokkinos PF, Fernhall B. Physical activity and high density lipoprotein cholesterol
levels: what is the relationship? Sports Med. 1999;28(5):307-14.
41.
Muga MA, Owili PO, Hsu CY, Rau HH, Chao JC. Association between dietary patterns and
cardiovascular risk factors among middle-aged and elderly adults in Taiwan: a population-based
study from 2003 to 2012. PLoS One.2016;11(7):e0157745. doi: 10.1371/journal.pone.0157745.
42.
Lim JH, Lee YS, Chang HC, Moon MK, Song Y. Association between dietary patterns and
blood lipid profiles in Korean adults with type 2 diabetes. J Korean Med Sci. 2011;26(9):1201-8.
43.
Zhang J, Wang Z, Wang H, Du W, Su C, Zhang J, et al. Association between dietary patterns
and blood lipid profiles among Chinese women. Public Health Nutr. 2016;19(18):3361-8.
44.
Gross GA. Drug and alcohol abuse and cholesterol levels. J Am Osteopath Assoc. 1994;94(1):55-6,
61-2.
45.
Van de Wiel A. The effect of alcohol on postprandial and fasting triglycerides. Int
J Vasc Med. 2012;2012:862504. doi: 10.1155/2012/862504.